Published in Surgery Litigation and Law Weekly, January 26th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Conceptus.
Report 1: Conceptus, Inc. (CPTS), developer of the Essure procedure, the first and only non-incisional permanent birth control method available, has been named to Deloitte's prestigious Technology Fast 500 Program.
This is a ranking of the fastest growing technology, media, telecommunications and life sciences companies by Deloitte & Touche USA LLP, one of the nation's leading professional services organizations. Rankings are based on the percentage revenue growth over five years...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly